ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 595,69
1,12%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adaptimmune Therapeutics PLC (ADAP)

  7. Adaptimmune Therapeutics PLC (ADAP) Actualités

ADAP Adaptimmune Therapeutics PLC

1,21
0,02 (1,68%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Adaptimmune Therapeutics PLC ADAP NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,02 1,68% 1,21 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,22 1,17 1,24 1,19 1,19
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/3/202413:05EDGAR2Form 8-K - Current report
27/2/202414:13EDGAR2Form 8-K - Current report
16/2/202422:05EDGAR2Form 8-K - Current report
31/1/202423:07EDGAR2Form 8-K - Current report
17/1/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:46EDGAR2Form 8-K - Current report
06/12/202313:13EDGAR2Form 8-K - Current report
30/11/202322:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202313:37EDGAR2Form 8-K - Current report
03/11/202321:15EDGAR2Form 8-K - Current report
31/10/202313:07EDGAR2Form 8-K - Current report
31/8/202323:19EDGAR2Form 8-K - Current report
10/8/202322:05EDGAR2Form 8-K/A - Current report: [Amend]
09/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202313:42EDGAR2Form 8-K - Current report
01/8/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202322:54EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/6/202322:25EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
ADAP
Adaptimmune Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés